Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Endovia Health Sciences, Inc.
Report date April 24, 2023 · Filed May 15, 2023
Section 16 reporting ended · disclosed 2023-05-15. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock optionsSEC Table II · derivative / convertible security · Conversion / exercise price $1.12 · Expires 2033-04-05 | Direct | 125,000 |
Reported balance
After 2023-04-24 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2023-04-24 · Grant · Acquired 125,000 · Balance 125,000 F1: The options are being issued in connection with serving on the board of directors of SBEV, pursuant to the 2020 Long-Term Incentive Compensation Plan. 10,417 options will vest on the 5th day of each month starting May 2023 until December 2023 and 10,416 options will vest on the 5th day of each month starting January 2024 until April 2024. |
Filing footnotes · ownership attribution and instrument terms
F1: The options are being issued in connection with serving on the board of directors of SBEV, pursuant to the 2020 Long-Term Incentive Compensation Plan. 10,417 options will vest on the 5th day of each month starting May 2023 until December 2023 and 10,416 options will vest on the 5th day of each month starting January 2024 until April 2024.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 24, 2023 Filed May 15, 2023 16:30 UTC | Endovia Health Sciences, Inc. SBEV · Entity 8508 | GrantStock options · Derivative | 125,000 | $0.00 Strike: $1.12 | $0.00 |
DisclosureSEC source: 0001731122-23-000934 · ownership.xml · derivative · entry 1 Crawford Candace · CIK 0001864097 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 125,000 Underlying: Common stock · 125,000 shares Expires 2033-04-05 F1 · derivative.exercise_date: The options are being issued in connection with serving on the board of directors of SBEV, pursuant to the 2020 Long-Term Incentive Compensation Plan. 10,417 options will vest on the 5th day of each month starting May 2023 until December 2023 and 10,416 options will vest on the 5th day of each month starting January 2024 until April 2024. Read SEC document |
| September 30, 2021 Filed Mar 31, 2022 21:44 UTC | Endovia Health Sciences, Inc. SBEV · Entity 8508 | GrantOption (Right to Buy) · Derivative | 125,000 | $0.00 Strike: $2.60 | $0.00 |
DisclosureSEC source: 0001731122-22-000657 · ownership.xml · derivative · entry 1 Crawford Candace · CIK 0001864097 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,000 Underlying: Common Stock · 125,000 shares Expires 2026-09-30 F1 · derivative.exercise_date: Two-thirds of the Options vested on September 30, 2021, and one-third of the Options vest on September 30, 2022. Read SEC document |
| May 16, 2021 Filed Apr 5, 2022 17:25 UTC | Endovia Health Sciences, Inc. SBEV · Entity 8508 | GrantOption (Right to Buy) · Derivative | 333,333 | $0.00 Strike: $2.25 | $0.00 |
DisclosureSEC source: 0001731122-22-000676 · ownership.xml · derivative · entry 1 Crawford Candace · CIK 0001864097 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 333,333 Underlying: Common Stock · 333,333 shares Expires 2026-05-15 F1 · derivative.exercise_date: One-third of the Options vested immediately, one-third of the Options vested on May 15, 2021, and one-third of the Options vest on May 15, 2022. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.